Keyphrases
Tumor Recurrence
100%
Antidepressant Use
100%
Meningioma
100%
Antidepressants
71%
Tumor
28%
Convexity
28%
Parasagittal
28%
Meningioma Recurrence
28%
Falcine
28%
Median Time
14%
Patient Management
14%
Protective Effect
14%
Glioma
14%
Clinical Factors
14%
Resection
14%
Parietal Lobe
14%
Tumor Location
14%
Clinical Measures
14%
Long-run Risk
14%
Tumor Characteristics
14%
Subtotal Resection
14%
Selective Serotonin Reuptake Inhibitors
14%
Skull Base
14%
Multivariate Logistic Regression
14%
Uptake Inhibitor
14%
Early Recurrence
14%
Tumor Outcome
14%
Affective Change
14%
Mood Changes
14%
WHO Grade II
14%
Intracranial Meningioma
14%
Recurrence Prediction
14%
Antidepressant Prescribing
14%
Inhibitor-2
14%
Medicine and Dentistry
Tumor Recurrence
100%
Meningioma
100%
Antidepressant
100%
Recurrent Disease
38%
Neoplasm
30%
Surgery
15%
Ganglioglioma
7%
Logistic Regression Analysis
7%
Parietal Lobe
7%
Skull Base
7%
Selective Serotonin Reuptake Inhibitor
7%
Reuptake Inhibitor
7%
Pharmacology, Toxicology and Pharmaceutical Science
Antidepressant
100%
Tumor Recurrence
100%
Meningioma
100%
Recurrent Disease
38%
Neoplasm
30%
Base
7%
Reuptake Inhibitor
7%
Selective Serotonin Reuptake Inhibitor
7%
Neuroscience
Antidepressant
100%
Meningioma
100%
Parietal Lobe
7%
Selective Serotonin Reuptake Inhibitor
7%
Skull Base
7%
Reuptake Inhibitor
7%